Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19

COVID‐19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD(+)) and glutathione metabolism. Here it is investigated if administration of a mixture of combined metabolic activators (CMAs) consisting of glutath...

Descripción completa

Detalles Bibliográficos
Autores principales: Altay, Ozlem, Arif, Muhammad, Li, Xiangyu, Yang, Hong, Aydın, Mehtap, Alkurt, Gizem, Kim, Woonghee, Akyol, Dogukan, Zhang, Cheng, Dinler‐Doganay, Gizem, Turkez, Hasan, Shoaie, Saeed, Nielsen, Jens, Borén, Jan, Olmuscelik, Oktay, Doganay, Levent, Uhlén, Mathias, Mardinoglu, Adil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420376/
https://www.ncbi.nlm.nih.gov/pubmed/34180141
http://dx.doi.org/10.1002/advs.202101222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420376/
https://www.ncbi.nlm.nih.gov/pubmed/34180141
http://dx.doi.org/10.1002/advs.202101222

Ejemplares similares